The Sustainability of Rising Drug Prices in Oncology
Ryan Bookout, PharmD, president, Hematology/Oncology Pharmacy Association, clinical pharmacist, Moffitt Cancer Center, discusses the sustainability of the field of oncology as drug prices continue to rise.
Implementing Quality Standards and Personalized Approaches into Oncology
Robert D. Orzechowski, MBA, chief operating officer, Lancaster Cancer Center, executive council member, NCODA, discusses the implementation of quality standards and personalized approaches into oncology.
Dr. Patel on the Importance of Biosimilars
Kashyap Patel, MD, president of the Carolina Blood and Cancer Center and medical director of the International Oncology Network, discusses the importance of biosimilars in oncology.
Dr. Patel on Cost-Effective Strategies for Oncologists
Kashyap Patel, MD, president, Carolina Blood and Cancer Center, medical director, International Oncology Network, discusses cost-effective practices for oncologists.
The Rise of Oral Oncolytics
Howard Cohen, RPh, MS, FASHP, director of oncology pharmacy services, Smilow Cancer Center, Yale New Haven Health, discusses the rise of oral oncolytics in the treatment landscape during the 2018 NCODA Fall Summit.
Biosimilars Among Several Measures Needed to Lower Oncology Costs
Kashyap Patel, MD, discusses biosimilars and other potential cost-controlling measures in cancer care.
The Impact of Precision Medicine in Oncology
Ryan Bookout, PharmD, president, Hematology/Oncology Pharmacy Association, clinical pharmacist, Moffitt Cancer Center, discusses the impact of recent advances and precision medicine in oncology.
Dr. Patel on Skepticism Associated With Biosimilars
Kashyap Patel, MD, president, Carolina Blood and Cancer Center, medical director, International Oncology Network, discusses skepticism associated with biosimilars in oncology.
Managing the Growth of NCODA
Bob Orzechowski, MBA, Lancaster Cancer Center, discusses managing the growth of NCODA.
Schwartz Discusses the Mission of NCODA
Jim Schwartz RPh, President, NCODA, discusses the mission of NCODA.
Patient Education on Oral Chemotherapy
Daniel DeRemer, PharmD, assistant director of Clinical Therapeutics and Incubator, discusses patient education on oral chemotherapy.
Payment Assistance for Patients With Cancer
Dan Klein, President and CEO of Patient Access Network Foundation, discusses payment assistance for patients with cancer.
Management of Patients with Cancer
Michael Broderson, PharmD, Nebraska Cancer Specialists, discusses the management of patients with cancer.
The Importance of the Oncologist in Physician Dispensing
Karen Kellogg, PharmD, Cardinal Health, discusses the important role that the oncologist plays in dispensing.
The Role of Positive Quality Interventions
Neal Dave, PharmD, Texas Oncology, discusses the role of positive quality interventions (PQI).
The Role of the Provider in Policy Reform
Randy Burkholder, vice president, Policy & Research, PhRMA, discusses the role that providers play in policy reform.
Dr. Bardia on Elacestrant in ER+/HER2– Metastatic Breast Cancer
Real-world Data Confirm Safety Profile for Tucatinib Plus Trastuzumab/Capecitabine in HER2+ Breast Cancer
Frontline Adagrasib Plus Pembrolizumab Elicits Encouraging Clinical Activity in KRAS G12C+ Advanced NSCLC
Frontline Dostarlimab Shows Superior PFS vs Pembrolizumab in NSCLC
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.